Network intervention for HIV Infections

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
HIV Infections
Network intervention - Behavioral
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial is testing if a network intervention can help Latino men who have sex with men and transwomen get regular HIV tests and prevent HIV transmission.

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: Past 12 months

Past 12 months
Mean percentage of participants who report having tested for HIV twice in the past 12 months.
Past 6 months
Mean percentage of PrEP-eligible participants who report having consulted with a provider about PrEP.
Mean percentage of participants who report having had unprotected sex with a casual partner.
Mean percentage of participants who report having tested for HIV in the past 6 months.

Trial Safety

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Standard of Care plus Network Intervention
1 of 2
Active Control
Experimental Treatment

456 Total Participants · 2 Treatment Groups

Primary Treatment: Network intervention · No Placebo Group · N/A

Standard of Care plus Network InterventionExperimental Group · 2 Interventions: Network intervention, HIV counseling and testing · Intervention Types: Behavioral, DiagnosticTest
Standard of Care
DiagnosticTest
ActiveComparator Group · 1 Intervention: HIV counseling and testing · Intervention Types: DiagnosticTest
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIV counseling and testing
2012
N/A
~490

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: past 12 months

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
554 Previous Clinical Trials
1,151,716 Total Patients Enrolled
11 Trials studying HIV Infections
3,826 Patients Enrolled for HIV Infections
National Institute of Mental Health (NIMH)NIH
2,522 Previous Clinical Trials
1,814,134 Total Patients Enrolled
270 Trials studying HIV Infections
468,340 Patients Enrolled for HIV Infections
Laura R GlasmanPrincipal InvestigatorMedical College of Wisconsin

Eligibility Criteria

Age 18+ · Male Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
People who identify as Latinx and are men who have sex with men or transgender women 18 or older.
Lives in the Milwaukee, Cleveland or Indianapolis area
Can provide their understanding of what they are consenting to.
Requirements for networks seeking to be included in the study: -The network must have a majority of Latinx people

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: October 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.